Ralph Lauren misses 3Q earnings and revenue expectations
Ralph Lauren Corp. (RL) on Wednesday reported fiscal third-quarter earnings of $215 million.
General Motors 2014 profit falls 26 pct. to $2.8B, would have had big year without recalls
If it weren't for the recalls, 2014 would have been a stellar year for General Motors.
Plunging oil prices hit Chevron 4th-quarter profit and revenue; company plans investment cuts
Chevron Corp. (CVX) said Friday its net income and revenue dropped in the fourth-quarter as oil and gas prices slumped, and the company said it plans significant cuts in spending in 2015.
Mattel 4Q results disappoint on soft Barbie, American Girl sales
Slumping sales of Barbie did little to bring a happy holiday to her maker, Mattel Inc.
Honda lowers forecasts, sees dip in quarterly profit after recall expenses counter cheap yen
Honda Motor Co., the Japanese automaker at the center of an air-bag defect scandal, lowered its annual earnings forecast after quarterly profit slipped 15 percent.
Big oil, big impact: Markets brace for plunge in profits as oil majors report 4Q results
It's just a forecast, and for only one of 10 industry groups in the stock market.
Business events and economic reports scheduled for the coming week
All times are Eastern MONDAY, Feb. 2 WASHINGTON — Commerce Department releases personal income and spending for December, 8:30 a.m.; Institute for Supply Management releases its manufacturing index for January, 10 a.m. Eastern; Commerce Department releases construction spending for December, 10 a.m.
Qualcomm posts 1Q profit, results top Street expectations
Qualcomm Inc. (QCOM) on Wednesday reported fiscal first-quarter earnings of $1.97 billion.
Fiat Chrysler earnings 2014 earnings down by 68 percent due mostly to costs of Chrysler deal
Carmaker Fiat Chrysler reported a two-thirds drop in 2014 earnings due mainly to costs of acquiring the final stake of U.S. carmaker Chrysler.
Amgen beats 4Q net income and revenue expectations
Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.
Hyundai Motor reports 22percent drop in 4Q earnings as emerging market currencies fell
Hyundai Motor Co. suffered a drop in quarterly earnings and is forecasting weak sales growth this year.
AbbVie shares slip after drugmaker issues 2015 earnings forecast deemed conservative
The price of AbbVie shares dipped early Friday after the drugmaker delivered what some analysts saw as a conservative forecast for 2015 earnings growth.
CVS Health raises quarterly dividend, forecasts 2015 earnings growth
CVS Health will raise its quarterly shareholder payout by 27 percent, and the nation's second-largest drugstore chain also said Tuesday that it expects another year of earnings growth in 2015.
Business events and economic reports scheduled for the coming week
All times are Eastern MONDAY, Nov. 24 BERLIN — Germany's Ifo institute releases its monthly business confidence index, a key indicator for Europe's biggest economy.
Best Buy reports unexpected sales gain in 3Q as holiday shopping season kicks off
Best Buy says its revenue edged up in the third quarter, a positive sign for the electronics retailer as the holiday season kicks off.
Halliburton, Allergan, Celldex, Exterran and Amicus Therapeutics are big market movers
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Halliburton Co., down $5.85 to $49.23 The oilfield services company is buying rival Baker Hughes Inc. in a cash-and-stock deal worth $34.6 billion as oil prices tumble.
Halliburton, Hertz, Nokia, Geron and Amazon are big market movers
Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Halliburton Co., up $1.29 to $55.08 The oilfield drilling and services company and its rival Baker Hughes Inc. are discussing a possible merger deal.
Orexigen Therapeutics rises as European Union review of weight loss drug continues
Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
Tesla delivers record 7,785 sedans in 3Qm, but loss widens on engineering costs
Electric car maker Tesla Motors set a quarterly record for deliveries of its Model S sedan, but its losses mounted due to increased engineering costs.
